Korro Bio, Inc. Increase (Decrease) in Accounts Payable
Korro Bio, Inc. (KRRO) reported Increase (Decrease) in Accounts Payable of $1.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Korro Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.10M, a 92.24% increase year-over-year.
- Korro Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$153.00K, a 254.55% decline year-over-year.
- Korro Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$637.00K.
- Korro Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.87M.
- Korro Bio, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$2.31M.
- Korro Bio, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$1.34M, a 143.26% decline from fiscal 2023.
- Korro Bio, Inc. increase (decrease) in accounts payable for fiscal 2023 was $3.10M, a 76.64% increase from fiscal 2022.
- Korro Bio, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.75M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.95M 10-Q · filed 2026-08-06 | $1.31M derived: sum of 3 quarters · filed 2026-08-06 | -$1.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$153.00K 10-Q · filed 2026-05-07 | -$790.00K derived: sum of 2 quarters · filed 2026-05-07 | -$3.66M derived: sum of 3 quarters · filed 2026-05-07 | -$2.56M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.50M derived: sum of 2 quarters · filed 2026-03-12 | -$2.41M derived: sum of 3 quarters · filed 2026-08-06 | -$2.31M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.77M derived: sum of 2 quarters · filed 2026-08-06 | -$1.67M 10-Q · filed 2025-11-12 | -$2.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.19M 10-Q · filed 2026-08-06 | $589.00K derived: sum of 3 quarters · filed 2026-08-06 | $360.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $99.00K 10-Q · filed 2026-05-07 | -$506.00K derived: sum of 2 quarters · filed 2026-05-07 | -$735.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.34M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$834.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.24M derived: sum of 3 quarters · filed 2026-03-12 | -$1.34M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.85M derived: sum of 2 quarters · filed 2025-11-12 | -$736.00K 10-Q · filed 2025-11-12 | $2.06M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$507.00K 10-Q · filed 2025-08-12 | $2.28M derived: sum of 3 quarters · filed 2025-08-12 | $2.25M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$2.58M 10-Q · filed 2025-05-07 | $206.00K derived: sum of 2 quarters · filed 2025-05-07 | $168.00K derived: sum of 3 quarters · filed 2025-05-07 | -$34.00K derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.75M derived: sum of 2 quarters · filed 2025-03-18 | $2.55M derived: sum of 3 quarters · filed 2025-03-18 | $3.10M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$240.00K derived: sum of 2 quarters · filed 2024-11-12 | $309.00K 10-Q · filed 2024-11-12 | -$2.78M 10-Q · filed 2023-11-02 | $1.60M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $347.00K 10-Q · filed 2024-08-13 | -$1.82M 10-Q · filed 2023-08-10 | $1.64M derived: sum of 3 quarters · filed 2024-08-13 | $1.30M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $549.00K 10-Q · filed 2024-05-14 | -$697.00K 10-Q · filed 2023-05-12 | $1.84M derived: sum of 2 quarters · filed 2024-05-14 | $1.51M derived: sum of 3 quarters · filed 2024-05-14 | $2.73M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $958.00K derived: sum of 2 quarters · filed 2024-03-26 | $2.18M derived: sum of 3 quarters · filed 2024-03-26 | $1.75M 10-K · filed 2024-03-26 | -$677.00K 10-K · filed 2023-03-10 | |||
| 2022-09-30 | -$338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $888.00K derived: sum of 2 quarters · filed 2023-11-02 | $459.00K 10-Q · filed 2023-11-02 | $77.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $797.00K 10-Q · filed 2023-08-10 | $415.00K derived: sum of 3 quarters · filed 2023-08-10 | $860.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$429.00K 10-Q · filed 2023-05-12 | -$811.00K derived: sum of 2 quarters · filed 2023-05-12 | -$366.00K derived: sum of 3 quarters · filed 2023-05-12 | -$875.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $63.00K derived: sum of 2 quarters · filed 2023-03-10 | -$446.00K derived: sum of 3 quarters · filed 2023-03-10 | -$2.29M 10-K · filed 2023-03-10 | ||||
| 2021-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$64.00K derived: sum of 2 quarters · filed 2022-11-08 | -$1.91M 10-Q · filed 2022-11-08 | -$493.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.35M 10-Q · filed 2022-08-09 | -$938.00K derived: sum of 3 quarters · filed 2022-08-09 | $961.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$1.85M 10-Q · filed 2022-05-04 | -$429.00K derived: sum of 2 quarters · filed 2022-05-04 | $1.47M derived: sum of 3 quarters · filed 2022-05-04 | $1.01M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.32M derived: sum of 2 quarters · filed 2022-03-15 | $2.85M derived: sum of 3 quarters · filed 2022-03-15 | $4.29M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.44M derived: sum of 2 quarters · filed 2021-11-15 | $2.87M 10-Q · filed 2021-11-15 | $515.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $971.00K 10-Q · filed 2021-08-12 | -$1.38M derived: sum of 3 quarters · filed 2021-08-12 | -$33.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.43M 10-Q · filed 2021-05-13 | -$923.00K derived: sum of 2 quarters · filed 2021-05-13 | $428.00K derived: sum of 3 quarters · filed 2021-05-13 | $694.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$1.00M derived: sum of 2 quarters · filed 2021-03-29 | -$738.00K derived: sum of 3 quarters · filed 2021-03-29 | -$644.00K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.62M derived: sum of 2 quarters · filed 2020-11-16 | $1.71M 10-Q · filed 2020-11-16 | $1.47M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $360.00K 10-Q · filed 2020-08-12 | $122.00K derived: sum of 3 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $94.00K 10-Q · filed 2020-05-14 | -$144.00K derived: sum of 2 quarters · filed 2020-05-14 | ||||||
| 2018-12-31 | -$238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $869.00K 10-K · filed 2020-03-26 | ||||||
| 2018-09-30 | $1.11M 10-Q · filed 2019-11-18 | |||||||
| 2017-12-31 | -$231.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |